We present the results of the first morphological study of a Gore® HELEX® Septal Occluder 30 mm that was explanted seven years after interventional implantation due to a significant left-to-right shunt (7 mm) which resulted from the stretching of the concomitant patent foramen ovale by the occluder after atrial septal defect closure. Complete endothelialization of the surface of the device, the formation of the connective tissue around the implant, minor chronic inflammation, the appearance of foreign body giant cells and weakened myocardial cells adjacent to the implant as well as enhanced expression of matrix metalloproteinases were demonstrated.
INTRODUCTION
Percutaneous transcatheter closure of secundum atrial septal defects (ASDs) is an effi cient and safe method in long-term with high procedural success rates.
Long-term complications are very rare which increases the importance of reporting them.
Th e Gore® HELEX® occluder is composed of a single piece of nickel-titanium (nitinol) wire with a patch of expanded polytetrafl uoroethylene (ePTFE) attached along its length. Th e elastic property of nitinol is used to form the wire frame into two opposing disks that bridge and close the septal defect. Th e ePTFE is specially designed to facilitate rapid cell penetration, thereby promoting rapid tissue ingrowth, resulting in permanent defect closure and device stability [7] . Endothelial, interstitial and infl ammatory cells that are located at the biomaterial interface can release various tissue mediators, remodel, and, even, degrade the tissue increasingly expressing matrix metallo proteinases (MMPs) [2] . MMPs oft en contribute to cardiovascular remodeling, and enhanced MMP expression is related to the variety of pathological processes and diseases, including aneurysm formation, atherosclerosis, myocardial infarction, hypertension, and cardiomyopathies [3] .
MATERIALS AND METHODS

Light microscopy
Aft er surgical explantation, the device was dissected and fi xed in 10% buff ered formalin. For light microscopy, the parts of the device containing only ePTFE without nitinol wire were dehydrated in a series of graded ethanols and embedded in paraffi n. Histological sections were stained routinely with hematoxylin and eosin (H&E) and Masson's trichrome. For immunohistochemistry, we used a panel of four anti-MMP antibodies: mouse monoclonal anti-MMP-2 (Novocastra, Newcastle, UK, Leica Biosystems, clone 17B11, 1:40), anti-MMP-9 (Novocastra, Newcastle, UK, Leica Biosystems, clone 15W2, 1:40), anti-MMP-10 (Novocastra, Newcastle, UK, Leica Biosystems, clone 5E4, 1:25), and rabbit polyclonal anti-MMP-3 (Biorbyt, Cambridge, UK, Biorbyt Ltd., 1:300) antibody; mouse monoclonal anti-CD34 (Cell Marque, Rocklin, CA, USA, clone QBEnd/10, 1:100), anti-CD68 (DacoCytomation, Glostrup, Denmark, clone PG-M1, 1:50), and anti-α-smooth muscle actin (SMA) (DacoCytomation, Glostrup, Denmark, clone 1A4, 1:100) antibodies. Th e antigen sites were visualized with 3,3'-diaminobenzidine (DAB) substrate kit (Cell Marque, Rocklin, CA, USA). Th e sections were counterstained with Mayer's hematoxylin. Th e expression of antigens was estimated at ×100 up to ×400 magnifi cation, using Leica light microscope (LEICA, LEITZ DMRB, Germany).
Electron microscopy
Th e explanted device and the adjacent tissue interface were studied by a scanning electron microscopy. Th e small part of the ePTFE patch and the adjacent cardiac tissue was fi xed in 2.5% glutaraldehyde, postfi xed in 1% OsO 4 , dehydrated, dried by the critical point method using liquid CO 2 , mounted onto metal stub, covered with gold using an automated sputter coater (JFC-1300, JEOL, Japan). Finally, samples were examined under a JSM-6490LV scanning electron microscope (JEOL, Japan) at accelerating voltage of 10kV using SEI mode and magnifi cation ×1000-×4000.
CASE REPORT
In December 2007, a 33-year-old female patient presented with complaints of fatigue, breathlessness on exertion and palpitations, and was admitted to Pauls Stradins Clinical University Hospital. Transesophageal echocardiography (TEE) revealed 8 mm large Ostium Secundum ASD. Additionally, a small patent foramen ovale (PFO) was also detected. Th e patient underwent a TEEguided transcatheter closure of ASD with stretched diameter of 15 mm using the Gore® HELEX® Septal Occluder 30 mm. Th e fi nal position of the device and its confi guration was stable but suboptimal with partial fl aring of the disks and non-signifi cant residual leak above the implant. Aft er consulting with device providers a decision was made to follow-up the patient. Aspirin 100 mg per day was started and continued for six months.
Th ere were no signifi cant shunt and the change of the device position revealed in one month transthoracic echocardiography examination. Th e patient was asymptomatic and was lost of follow-up for six years until presented in January 2014 with exertional dyspnea, dizziness, and fatigue for six months. By TEE a signifi cant left -to-right shunt of 7 mm through the PFO resulting from the stretching of the PFO by the device was revealed. Th e device was explanted, and a surgical closure of interatrial communication by primary suture closure was performed. Postoperative echocardiography confi rmed immediate complete closure of ASD.
RESULTS
Gross pathology
By gross examination, the Gore® HELEX® Septal Occluder appeared to be completely covered by a smooth whitish layer of tissue revealing thorough endothelialization. Th e nitinol frame of the device was covered only by a thin layer of tissue and remained visible through it. Th e wire appeared macroscopically intact and without ruptures. No thrombi or vegetations were found adjacent to the device.
Light microscopy, immunohistochemistry and electron microscopy
By histological examination, no fi brin deposits or evidence of acute infl ammation were detected. Following recommendations, published previously [4] , the following regions of the specimen were distinguished: the outer cellular layer of the neoendothelium, pseudointimal connective tissue inserted between the neoendothelium and the device, and the neotissue represented by the connective tissue between the disks of the occluder. We found complete endothelialization of the luminal surface of the device, consisting of a single layer of CD34-positive endothelial cells. In turn pseudointima was identifi ed composing of the dense connective tissue, sparse capillaries and few spindleshaped fi broblast-like cells oriented parallel to the neoendothelium. Th ese cells were α-SMA-positive. Interestingly, because of the microporous structure of ePTFE, we observed deep tissue ingrowth inside the patch itself. By contrast, to pseudointima, the neotissue consisted of the loose connective tissue with welldeveloped vascularization and abundant chaotically oriented fi broblast-like cells that stained positive for α-SMA. Importantly, along with the inner surface of the ePTFE patch, we found numerous multinucleated CD68-positive foreign body giant cells arranged in a single row at the cardiac tissue-device material interface (Fig. 1) . Additionally, minor lymphocytic and plasmacytic infi ltration was observed within the loose connective tissue in regions of marked angiogenesis.
Studying possible long-term eff ects of insuffi ciently functioning occluder, and its associated foreign body reaction as well as remodelling of cardiac tissue by the estimation of MMPs we found marked expression of MMP-9 by endothelium, foreign body giant cells, macrophages, fi broblasts-like cells and cardiomyocytes (Fig. 2) , whereas the expression of MMP-2, 3 and 10 was almost nil. Additionally, we observed extracellular MMP-9 related immunostaining in the dense connective tissue of the pseudointima revealing uniformly stained collagen fi bers. Interestingly, that the loose connective tissue of the neotissue did not stain immunopositive for MMP-9 when compared to the pseudointima.
We noted that the atrial myocardium located near the device showed marked morphological alteration, particular cardiomyocyte hypertrophy, the enlargement of nuclei and cytoplasmic myofi lament destruction. Th ese changes were accompanied by fi brotic tissue ingrowth into the myocardium (Fig. 3) .
Th e myocardium obtained for the ultrastructural studies consisted of diff erently shaped and sized muscle cells which slightly bifurcated and connected with neighbouring cells, mostly at the ends of cellular trunks. Th e cytoplasm of cardiomyocytes revealed a varying number of microfi laments, diff erently sized and oriented mitochondria, and tubules of the endoplasmic reticulum (Fig. 4) . Some cardiomyocytes showed loosening of the cytoplasmic content.
DISCUSSION
Over the past decade, the interventional closure of amenable ASD has become the treatment of choice in most centers worldwide. However, very limited data deciphering histopathological changes and some aspects of biocompatibility of ASD closure devices in humans is currently available [5] . Some of these studies were performed on explanted the Amplatzer® Atrial Septal Defect Occluder that was the fi rst occlusion device to obtain approval for commercialization. To date, only two devices have been approved by the US FDA with an indication for the transcatheter closure of ASD: the Amplatzer® Atrial Septal Defect Occluder (December 2001) and the Gore® HELEX® Atrial Septal Defect Occluder (August 2006) [5] .
In contrast to the former, to our knowledge, there are no morphological studies on explanted Gore® HELEX® atrial septal defect occluder in humans, except for the only one study performed on dogs [7] .
Th e major drawback of the previous histopathological studies is that these studies were conducted investigating a short period of implantation set between three months and two years aft er device implantation. Since the implanted devices are expected to function lifelong, it could be too little time to assess local tissue response and biocompatibility. In our case, the device was explanted seven years aft er implantation.
As was described in the previous reports of the Amplatzer® Atrial Septal Defect Occluder, we found foreign body giant cells located at the tissue-material interface -a convincing evidence of a chronically persisting infl ammatory response [1, 4, 5, 6] . It is supposed that foreign body giant cells can release various tissue remodeling mediators and lead to the degradation of several biomaterials with subsequent device failure [2] . Additionally, lymphocytic and plasmacytic infi ltration was also observed. Whether this ongoing infl ammatory reaction, directed against the implanted device, could result in device dysfunction or impact on its safety is unknown. To date, there are no reported adverse short-term and long-term eff ects of foreign body immune reaction to nitinol wire and ePTFE patch.
Biomaterial adherent macrophages can secrete a variety of proteins that modulate fi brosis and form a fi brous capsule around the device [2] . To study possible eff ects of giant cells on cardiac tissue and extracellular matrix (ECM) remodeling, we performed immunohistochemical analysis of the explanted device using antibodies to MMPs, CD34, CD68, and SMA. We found marked extracellular and cytoplasmic expression of MMP-9 in vascular endo thelium, foreign body giant cells, macrophages, fi broblasts-like cells and cardiomyocytes. It is worth noting that the levels of MMPs expression were greatly varying. Th e expression of MMP-2, 3 and 10 was almost nil, whereas the levels of MMP-9 expression were high. Collagen fi bers were stained immunopositive in the outer dense connective tissue layer (pseudointima) but no expression was found in the inner loose connective tissue layer (neotissue). Th e higher degree of ECM remodeling in the pseudointima may subsequently lead to the excessive encapsulation of the device.
Th e most striking fi nding was a morphological heterogeneity and the distortion of cardiomyocytes, and loosening of the cytoplasmic organelles including microfi laments. Additionally, fi brotic changes in the myocardium were also noted. Whether these alterations in the myocardium are the results of the enhanced MMP-9 expression and foreign body immune reaction or hemodynamic characteristics attributable to the signifi cant left -to-right shunt over PFO, is a matter of debate. It was described previously, that enhanced MMPs expression could be associated with the variety of cardiovascular diseases, including aneurysm formation, atherosclerosis, myocardial infarction, hypertension, and cardiomyopathies. However, these pathological processes were described for MMP-2 [3] . In our study, we found only the MMP-9 expression, which together with MMP-2 constitute the same group of gelatinases. According to our results, MMP-9 might have a signifi cant role in maintaining chronic infl ammatory response with the foreign body reaction and promoting fi brous encapsulation of the implanted device.
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